Abstract
The antinociceptive activity of antidepressant drugs is poorly understood. In this study, using the acetic acid writhing test in mice, the antinociception produced by clomipramine (CLO), maprotiline (MAP), imipramine (IMI), and zimelidine (ZIM) was tested and correlated with opioid drugs. All the compounds displayed a significant dose-dependent antinociception, which was not antagonized by naloxone (NX) or naltrexone (NTX). The administration of morphine (M) plus CLO, MAP, IMI or ZIM resulted in a significant additive effect that was antagonized by 1 or 10 mg/kg NX or NTX, except in the case of IMI. This finding suggests that the additive effect seems to be partially due to activation of opioid receptors, except for the case of imipramine. However, aminophylline, a non-selective blocker of A1/A2 adenosine receptors, significantly antagonized the antinociceptive activity of CLO, IMI, MAP and ZIM, demonstrating an interaction at the level of adenosine receptors. This work suggests that the antinociceptive activity of antidepressants could be dependent on critical levels of free 5-HT and NE at receptor(s) site(s) in CNS and on their interaction with opioid and adenosine receptors.
Similar content being viewed by others
References
Ardid D, Guilbaud G (1992) Antinociceptive effects of acute and “chronic” injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 49:279–287
Bhargava HN, Larsen AK, Rahmani NH, Villar VM (1993) Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat. Brain Res 607:1–8
Bergman SA, Wynn RL, Alvarez L, Asher K, Thut PD (1991) Imipramine-fentanyl antinociception in a rabbit booth pulp model. Life Sci 49:1279–1288
Biegon A, Samuel D (1980) Interaction of tricyclic antidepressants with opiate receptors. Biochem Pharmacol 29:460–462
Botney M, Fields HL (1983) Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 13:160–164
Carr DJ, Gerak LR, Franz CP (1994) Naltrexone antagonizes the analgesia and immunosuppressive effects of morphine in mice. J Pharmacol Exp Ther 269:693–698
Committee for Research and Ethical Issues of the IASP (1983) Ethical standards for investigations of experimental pain in animals. Pain 16:109–110
Crisp T, Stafinsky JL, Spanos LJ, Uram M, Perni VC, Donepudi HB (1991) Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. Gen Pharmacol 22:247–251
Daval JL, Nehlig A, Nicolas F (1991) Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 49:1435–1453
Enna SJ, Kendall DA (1981) Interaction of antidepressants with brain neurotransmitter receptors. J Clin Psychopharmacol 1:12–16
Fasmer OB, Kunskaar S, Hole K (1989) Antinociceptive effects of serotonergic reuptake inhibitors in mice. Neuropharmacology 28:1363–1366
Fuller RWG (1981) Enhancement of monoaminergic neurotransmission by antidepressant drugs. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: neurochemicals, behavioral and clinical perspectives. Raven Press, New York, pp 1–12
Goldstein FJ, Mojaverian P, Ossipov MH, Swamson BN (1982) Elevation in analgesic effect and plasma levels of morphine by desipramine in rats. Pain 14:279–282
Goldstein FJ, Malseed RT, Nutz JF (1990) Effects of chronic clomipramine on central DADLE antinociception. Pain 42:331–336
Hayashi G, Takemori AE (1971) The type of analgesic-receptor interaction involved in certain analgesic assays. Eur J Pharmacol 16:63–66
Ho IK, Loh HH, Way EL (1973) Cyclic adenosine monophosphate antagonism of morphine analgesia. J.Pharmacol Exp Ther 185:336–346
Jensen TS, Yaksh TL (1984) Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brain stem sites. Brain Res 321:287–297
Jurna I (1981) Aminophylline differentiates between the depressants effects of morphine on the spinal nociceptive reflex and on the spinal ascending activity evoked from afferent C fibers. Eur J Pharmacol 71:393–400
Kilpatrick GJ, Bunce KT, Tyers MB (1990) 5-HT3 receptors. Med Res Rev 10:441–475
Larsen JJ, Arnt J (1984) Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats. Acta Pharmacol Toxicol 54:72–75
Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98
Magni G (1991) The use of antidepressants in the treatment of chronic pain. Drugs 42:730–748
Ollat H, Parvez S, Parvez H (1989) Endogenous morphines and nociception. Biogenic Amines 6:381–410
O'Neill KA, Valentino D (1986) Chronic desipramine attenuates morphine analgesia. Pharmacol Biochem Behav 24:155–158
Pick CG, Paul D, Eison MS, Pasternak GW (1992) Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 211:375–381
Reichenberg K, Gaillard-Plaza G, Montastruc JL (1985) Influence of naloxone on the antinociceptive effects of some antidepressant drugs. Arch Int Pharmacodyn Ther 275:78–85
Reisine T, Soubrie P (1982) Loss of rat cerebral cortical opiates receptors following chronic desipramine treatment. Eur J Pharmacol 77:39–44
Rosenblatt MR, Reich J, Dehring D (1984) Tricyclic antidepressants in treatment of depression and chronic pain. Anesth Analg 63:1025–1032
Sawynok J, Reid A (1992) Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine. Pain 50:113–118
Sierralta F, Miranda HF (1993) Adenosine modulates the antinociceptive action of benzodiazepines. Gen Pharmacol 24:891–894
Smits SE, Takemori AE (1970) Quantitative studies on the antagonism by naloxone of some narcotics and narcotic-antagonist analgesics. Br J Pharmacol 39:627–638
Stirt JA (1983) Aminophylline may act as a morphine antagonist. Anaesthesia 38:275–278
Taiwo YO, Fabian A, Pazoles CJ, Fields HL (1985) Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 21:329–337
Takemori AE, Kupferberg HJ, Miller JW (1969) Quantitative studies on the antagonism of morphine by nalorphine and naloxone. J Pharmacol Exp Ther 169:39–45
Takemori AE, Larson DL, Portoghese PS (1981) The irreversible narcotic antagonist and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 70:445–451
Tura B, Tura SM (1990) The analgesic effect of tricyclic antidepressants. Brain Res 518:19–22
Tyers MB (1982) Studies on the antinociceptive activities of mixtures of mu and kappa opiate receptor agonists and antagonists. Life Sci 31:1233–1234
Valeri P, Pimpinella G, Morrone LA, Romanelli L (1991) Antinociceptive effects of trazodone and m-chlorophenyl-piperazine (mCPP) in mice: interaction with morphine. Gen Pharmacol 22:127–131
Van Paag HM (1983) In search of the mode of action of antidepressants. Neuropharmacology 22:433–440
Ward SJ, Takemori AE (1983) Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J. Pharmacol Exp Ther 224:525–530
Wong CL, Bentley GA (1978) Increased antagonist potency of naloxone caused by morphine pretreatment. Eur J Pharmacol 47:415–422
Yang SW, Zhang ZH, Chen JY, Xie YF, Qiao JT, Dafny N (1994) Morphine and norepinephrine-induced antinociception at the spinal level is mediated by adenosine. Neuroreport 5:1441–1444
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sierralta, F., Miranda, H.F., Pinardi, G. et al. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacology 122, 374–378 (1995). https://doi.org/10.1007/BF02246269
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246269